Changeflow GovPing Pharma & Drug Safety Compositions and methods for protecting against...
Routine Notice Added Final

Compositions and methods for protecting against airborne pathogens and irritants

Favicon for changeflow.com ChangeBridge: Patent Grants - Biotech (C12N)
Published April 7th, 2026
Detected April 7th, 2026
Email

Summary

USPTO granted Patent US12594285B2 to Applied Biological Laboratories, Inc. covering antimicrobial compositions for protecting respiratory membranes against airborne pathogens including bacteria, fungi, and viruses. The patent contains 8 claims and relates to methods for preventing and treating respiratory infections through inhalation or ingestion of pathogens.

What changed

USPTO issued Patent US12594285B2 (Kind B2) to Applied Biological Laboratories, Inc. on April 7, 2026. The patent covers compositions and methods for enhancing respiratory membrane filtering capability to protect subjects from respiratory infections caused by airborne bacteria, fungi, and viruses. The filing date was October 8, 2021, with Application No. 17497813 and 8 total claims.

This patent grant establishes intellectual property rights for Applied Biological Laboratories, Inc. No immediate compliance actions are required by third parties. Competitors developing similar antimicrobial respiratory protection compositions should review this patent to assess potential infringement risks or licensing opportunities.

Source document (simplified)

← USPTO Patent Grants

Compositions and methods for protecting against airborne pathogens and irritants

Grant US12594285B2 Kind: B2 Apr 07, 2026

Assignee

APPLIED BIOLOGICAL LABORATORIES, INC.

Inventors

Nazlie Latefi

Abstract

The present disclosure features methods and compositions for enhancing the ability of the respiratory membranes to filter airborne pathogens and protect a subject from respiratory infections that result from inhalation or ingestion of such pathogens. In particular, the disclosure provides antimicrobial compositions that prevent and treat respiratory infections caused by bacteria, fungi, and viruses.

CPC Classifications

A61K 31/7012 A61K 9/0019 A61K 9/0043 A61K 9/0073 A61K 31/352 A61K 31/7016 A61K 33/30 A61K 33/34 A61K 33/38 A61K 36/28 A61K 36/328 A61K 36/53 A61K 36/752 A61K 38/1774 A61K 38/40 A61K 38/47 A61K 45/06 A61K 47/10 A61K 47/26 A61K 47/44 A61P 11/00 A61P 31/00 C12Y 302/01017 C12N 9/24 C12N 2760/16263

Filing Date

2021-10-08

Application No.

17497813

Claims

8

View original document →

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
April 7th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12594285B2

Who this affects

Applies to
Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Consumer Protection

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Biotech (C12N) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.